US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Braveheart Bio

21.41

+1.215.99%

Post-market: 21.830.4200+1.96%19:40 EDT

Volume:669.40K

Turnover:14.34M

Market Cap:1.93B

PE:-1.46

High:22.36

Open:19.90

Low:19.88

Close:20.20

52wk High:32.00

52wk Low:19.88

Shares:90.04M

Float Shares:25.83M

Volume Ratio:1.14

T/O Rate:2.59%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-14.6845

EPS(LYR):-17.2003

ROE:--

ROA:--

PB:-20.10

PE(LYR):-1.24

Loading ...

Overview Company News Filings

Braveheart Bio falls -13.9%

Goldman Sachs Remains a Buy on Braveheart Bio, Inc. (BRVE)

Analysts Offer Insights on NA Companies: IMAX (IMAX) and Braveheart Bio, Inc. (BRVE)

Braveheart Bio Q2 EPS $(2.51)

Benzinga Earnings

Earnings Flash (BRVE) Braveheart Bio Posts Q2 Loss $2.51 per Share

MT Newswires Live

Braveheart Bio Q2 FY26 Net Loss Widens to $15 Million; R&D Expenses Rise to $11.1 Million

Braveheart Bio, - Q2 Net Loss Attributable to Common Stockholders was $18.60 Mln or $2.51 Per Share

THOMSON REUTERS

Braveheart Bio Reports Second Quarter 2026 Financial Results and Provides Business Update

THOMSON REUTERS

Analysts Offer Insights on NA Companies: Braveheart Bio, Inc. (BRVE) and TeraWulf Inc (WULF)

Braveheart Bio to Participate in Cantor Global Healthcare Conference

Braveheart Bio Initiated at Buy by Stifel

Cantor Fitzgerald Initiates Braveheart Bio at Overweight With $40 Price Target

MT Newswires Live

Stifel Initiates Braveheart Bio at Buy With $45 Price Target

MT Newswires Live

Braveheart Bio, Inc. : TD Cowen Initiates Coverage with Buy Rating

THOMSON REUTERS

Braveheart Bio initiated with a Buy at Jefferies

Braveheart Bio initiated with a Buy at Goldman Sachs

U.S. Research Roundup-Adobe, Braveheart Bio, CACI International

TipRanks Analyst Salveen Richter Reiterates Buy on Braveheart Bio, Sets $48 12-Month Target on Strong HCM Opportunity for Lead Asset BHB-1893

Braveheart Bio Director Vineeta Agarwala Files Initial Beneficial Ownership Statement

Insiders Double Down on Braveheart Bio in Massive Confidence Play

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/BRVE/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BRVE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BRVE\",,,,,undefined,":{"symbol":"BRVE","market":"US","secType":"STK","nameCN":"Braveheart Bio","latestPrice":21.41,"timestamp":1790884800000,"preClose":20.2,"halted":0,"volume":669404,"hourTrading":{"tag":"盘后","latestPrice":21.83,"preClose":21.41,"latestTime":"19:40 EDT","volume":6714,"amount":143839.28,"timestamp":1790898027302,"change":0.42,"changeRate":0.019617,"amplitude":0.019617},"delay":0,"changeRate":0.05990099009900995,"floatShares":25831738,"shares":90039000,"eps":-14.684527,"marketStatus":"Closed","change":1.21,"latestTime":"10-01 16:00:00 EDT","open":19.9,"high":22.355,"low":19.88,"amount":14339530.011956,"amplitude":0.122525,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-14.684527,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1790928000000},"marketStatusCode":5,"adr":0,"listingDate":1785988800000,"exchange":"NASDAQ","adjPreClose":20.2,"preHourTrading":{"tag":"盘前","latestPrice":20,"preClose":20.2,"latestTime":"09:29 EDT","volume":21,"amount":421.59999,"timestamp":1790861399055,"change":-0.2,"changeRate":-0.009901,"amplitude":0.009901},"postHourTrading":{"tag":"盘后","latestPrice":21.83,"preClose":21.41,"latestTime":"19:40 EDT","volume":6714,"amount":143839.28,"timestamp":1790898027302,"change":0.42,"changeRate":0.019617,"amplitude":0.019617},"volumeRatio":1.136531},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BRVE\",,,,,undefined,":{"symbol":"BRVE","floatShares":25831738,"roa":"--","roe":"--","lyrEps":-17.200311,"volumeRatio":1.136531,"shares":90039000,"dividePrice":0,"high":22.355,"amplitude":0.122525,"preClose":20.2,"low":19.88,"week52Low":19.88,"pbRate":"-20.10","week52High":32,"institutionHeld":0,"latestPrice":21.41,"eps":-14.684527,"divideRate":0,"volume":669404,"delay":0,"ttmEps":-14.684527,"open":19.9,"prevYearClose":18,"prevWeekClose":20.62,"prevMonthClose":20.2,"prevQuarterClose":20.2,"fiveDayClose":23.37,"twentyDayClose":26.95,"sixtyDayClose":18},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BRVE\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BRVE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BRVE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1788926400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BRVE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BRVE","date":"2026-09-30","current":-1.457997,"percent":0.871795,"low":-23.993466,"twenty":-22.06759,"median":-20.842324,"eighty":-16.773912,"high":-12.297967,"avg":-19.651355,"sd":2.991281,"marketCap":1464634862},"quantilePoints":[{"date":"2026-08-07","current":-22.904964,"twenty":-19.277064,"median":-13.835213,"eighty":-12.912865,"marketCap":1837733965},{"date":"2026-08-14","current":-20.770344,"twenty":-22.55018,"median":-20.842324,"eighty":-16.302149,"marketCap":1666466982},{"date":"2026-08-21","current":-21.930028,"twenty":-22.591769,"median":-21.618113,"eighty":-20.309669,"marketCap":1759511923},{"date":"2026-08-28","current":-22.281932,"twenty":-22.249941,"median":-22.006007,"eighty":-20.827928,"marketCap":1787746250},{"date":"2026-09-04","current":-21.010278,"twenty":-22.169963,"median":-21.930028,"eighty":-20.827928,"marketCap":1685717659},{"date":"2026-09-11","current":-18.437402,"twenty":-22.185958,"median":-21.618113,"eighty":-20.469626,"marketCap":1748603206},{"date":"2026-09-18","current":-18.748639,"twenty":-22.118777,"median":-21.390175,"eighty":-18.607905,"marketCap":1778120911},{"date":"2026-09-25","current":-16.155238,"twenty":-22.096383,"median":-21.010278,"eighty":-18.113986,"marketCap":1532162790},{"date":"2026-09-30","current":-15.443219,"twenty":-22.06759,"median":-20.842324,"eighty":-16.773912,"marketCap":1464634862}],"updateTime":1790899201371},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BRVE\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669716264","title":"Braveheart Bio falls -13.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669716264","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669716264?lang=en_us&edition=fundamental","pubTime":"2026-09-22 00:00","pubTimestamp":1790006409,"startTime":"0","endTime":"0","summary":"Braveheart Bio (BRVE) is down -13.9%, or -$4.06 to $25.14. Published first on TheFly – the ultimate source for real-time, market-moving breaking fi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/braveheart-bio-falls-13-9-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/braveheart-bio-falls-13-9-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BRVE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666538872","title":"Goldman Sachs Remains a Buy on Braveheart Bio, Inc. (BRVE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666538872","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666538872?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:55","pubTimestamp":1788954946,"startTime":"0","endTime":"0","summary":"Goldman Sachs analyst Salveen Richter maintained a Buy rating on Braveheart Bio, Inc. yesterday and set a price target of $48.00. The company’s sha...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/goldman-sachs-remains-a-buy-on-braveheart-bio-inc-brve-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/goldman-sachs-remains-a-buy-on-braveheart-bio-inc-brve-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSX","LU2237443622.USD","LU0061475181.USD","LU1868836757.USD","LU1144417596.USD","LU1791807156.HKD","LU1868836591.USD","LU2750360997.AUD","BRVE","IE00B19Z3581.USD","IE0004086264.USD","LU0096364046.USD","LU2237443382.USD","LU2237438978.USD","LU2896262040.SGD","BK4588","LU0048573561.USD","LU1894683348.USD","LU2265009873.SGD","LU1894683264.USD","LU2471134952.CNY","LU0942090050.USD","LU1868836914.USD","BK4127","LU2237443549.SGD","IE0034235188.USD","BK4550","LU1868837136.USD","IE0004091025.USD","LU2237443895.HKD","LU2471134523.USD","IE00BSNM7G36.USD","BK4533","LU0210536198.USD","LU0345770993.USD","LU1804176565.USD","IE00BFXG1179.USD","LU2237443978.SGD","LU2471134879.HKD","BK4552","LU2750360641.GBP","LU0345770308.USD","LU0742534661.SGD","LU0868494617.USD","BK4504","BK4007","LU1668664300.SGD","LU0251142724.SGD","LU0251131958.USD","IE00B19Z3B42.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666587784","title":"Analysts Offer Insights on NA Companies: IMAX (IMAX) and Braveheart Bio, Inc. (BRVE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666587784","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666587784?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:10","pubTimestamp":1788952247,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the NA sector as 2 analysts just weighed in on IMAX (IMAX) and Braveheart Bio, Inc. (BRVE) with bullish sen...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-imax-imax-and-braveheart-bio-inc-brve-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-imax-imax-and-braveheart-bio-inc-brve-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4108","IMAX","BK4007","BK4141","NA","BRVE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666377403","title":"Braveheart Bio Q2 EPS $(2.51)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666377403","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666377403?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:37","pubTimestamp":1788899876,"startTime":"0","endTime":"0","summary":"Braveheart Bio (NASDAQ:BRVE) reported quarterly losses of $(2.51) per share which missed the analyst consensus estimate of $0.74 by 439.19 percent. This is a 1692.86 percent decrease over losses of $(0.14) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/09/61673604/braveheart-bio-q2-eps-2-51","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Braveheart Bio Q2 EPS $(2.51)","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BRVE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666773503","title":"Earnings Flash (BRVE) Braveheart Bio Posts Q2 Loss $2.51 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2666773503","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666773503?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:13","pubTimestamp":1788898431,"startTime":"0","endTime":"0","summary":"Earnings Flash (BRVE) Braveheart Bio Posts Q2 Loss $2.51 per Share","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BRVE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666854377","title":"Braveheart Bio Q2 FY26 Net Loss Widens to $15 Million; R&D Expenses Rise to $11.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2666854377","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666854377?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:08","pubTimestamp":1788898095,"startTime":"0","endTime":"0","summary":"Braveheart Bio Q2 FY26 net loss widens to $15 million; R&D expenses rise to $11.1 millionBraveheart Bio posted a Q2 net loss of $15 million, versus a $0.4 million loss a year earlier.Net loss attribut","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL8kvcjS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BRVE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666377601","title":"Braveheart Bio, - Q2 Net Loss Attributable to Common Stockholders was $18.60 Mln or $2.51 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2666377601","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666377601?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:03","pubTimestamp":1788897781,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA1VZYZG:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BRVE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666372798","title":"Braveheart Bio Reports Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2666372798","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666372798?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:03","pubTimestamp":1788897781,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA1VZYZG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BRVE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665901263","title":"Analysts Offer Insights on NA Companies: Braveheart Bio, Inc. (BRVE) and TeraWulf Inc (WULF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2665901263","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665901263?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:10","pubTimestamp":1788768608,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the NA sector as 2 analysts just weighed in on Braveheart Bio, Inc. (BRVE) and TeraWulf Inc (WULF) with bul...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-braveheart-bio-inc-brve-and-terawulf-inc-wulf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-braveheart-bio-inc-brve-and-terawulf-inc-wulf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4600","BK4007","BRVE","NA","WULX","BK4141","WULF","FDIG","BK4595","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664086926","title":"Braveheart Bio to Participate in Cantor Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664086926","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664086926?lang=en_us&edition=fundamental","pubTime":"2026-09-02 04:30","pubTimestamp":1788294600,"startTime":"0","endTime":"0","summary":"SAN FRANCISCO, Sept.  01, 2026 (GLOBE NEWSWIRE) -- Braveheart Bio, Inc. (Nasdaq: BRVE), a clinical-stage biopharmaceutical company developing next-generation therapeutics for hypertrophic cardiomyopat","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3354630/0/en/braveheart-bio-to-participate-in-cantor-global-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0511384066.AUD","BK4585","LU0154245673.USD","LU2463526074.USD","MADE","HCM","LU0289961442.SGD","CMI","BK4581","BRVE","BK4588","LU0069063385.USD","LU0203345920.USD","BK4567","LU0154245756.USD","LU0124676726.USD","LU0029874061.USD","BK4533","HCSG","LABU","IE000M9KFDE8.USD","LU0689626769.HKD","LU0289739343.SGD","BK4137","LU0472753341.HKD","LU0128526141.USD","LU0203347892.USD","BK4531","BK4007","XLV","XBI","BK4149","LU0057025933.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663072364","title":"Braveheart Bio Initiated at Buy by Stifel","url":"https://stock-news.laohu8.com/highlight/detail?id=2663072364","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663072364?lang=en_us&edition=fundamental","pubTime":"2026-08-31 18:36","pubTimestamp":1788172560,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BRVE/analyst-ratings","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BRVE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663224074","title":"Cantor Fitzgerald Initiates Braveheart Bio at Overweight With $40 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2663224074","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663224074?lang=en_us&edition=fundamental","pubTime":"2026-08-31 18:32","pubTimestamp":1788172345,"startTime":"0","endTime":"0","summary":"Cantor Fitzgerald Initiates Braveheart Bio at Overweight With $40 Price Target","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BRVE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663718150","title":"Stifel Initiates Braveheart Bio at Buy With $45 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2663718150","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663718150?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:49","pubTimestamp":1788169786,"startTime":"0","endTime":"0","summary":"Stifel Initiates Braveheart Bio at Buy With $45 Price Target","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BRVE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663079570","title":"Braveheart Bio, Inc. : TD Cowen Initiates Coverage with Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2663079570","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663079570?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:38","pubTimestamp":1788169103,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S05T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BRVE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663076785","title":"Braveheart Bio initiated with a Buy at Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2663076785","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663076785?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:06","pubTimestamp":1788167163,"startTime":"0","endTime":"0","summary":"Jefferies initiated coverage of Braveheart Bio (BRVE) with a Buy rating and $48 price target The two Phase II datasets from the company’s China par...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/braveheart-bio-initiated-with-a-buy-at-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/braveheart-bio-initiated-with-a-buy-at-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BRVE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663341075","title":"Braveheart Bio initiated with a Buy at Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2663341075","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663341075?lang=en_us&edition=fundamental","pubTime":"2026-08-31 16:35","pubTimestamp":1788165310,"startTime":"0","endTime":"0","summary":"Goldman Sachs analyst Salveen Richter initiated coverage of Braveheart Bio (BRVE) with a Buy rating and $48 price target Braveheart is a clinical-s...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/braveheart-bio-initiated-with-a-buy-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/braveheart-bio-initiated-with-a-buy-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2237443895.HKD","GSX","LU0096364046.USD","LU1804176565.USD","LU1868836757.USD","LU1894683264.USD","IE0034235188.USD","BK4516","LU0345770308.USD","BK4127","LU0868494708.USD","LU0048573561.USD","LU2471134796.USD","LU1144417596.USD","IE00B19Z3581.USD","LU0742534661.SGD","IE00BFXG1179.USD","LU2471134879.HKD","LU0251142724.SGD","IE0004086264.USD","LU2265009873.SGD","LU2471134523.USD","LU2750360997.AUD","LU0061475181.USD","LU1868836591.USD","LU1668664300.SGD","BK4007","IE00BSNM7G36.USD","LU2237438978.USD","LU0345770993.USD","LU2750360641.GBP","IE00B19Z3B42.SGD","LU0942090050.USD","LU2237443549.SGD","BK4533","LU1791807156.HKD","LU1894683348.USD","LU2237443978.SGD","BK4504","LU1868836914.USD","LU2237443382.USD","LU0210536198.USD","LU2896262040.SGD","LU1868837136.USD","BK4588","LU0106831901.USD","LU2471134952.CNY","BRVE","BK4552","IE0004091025.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663020059","title":"U.S. Research Roundup-Adobe, Braveheart Bio, CACI International","url":"https://stock-news.laohu8.com/highlight/detail?id=2663020059","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663020059?lang=en_us&edition=fundamental","pubTime":"2026-08-31 15:24","pubTimestamp":1788161046,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Adobe, Braveheart Bio, CACI InternationalAug 31 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Adob","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL4N44S0J8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SBRA","BAC","OHI","HQY","LUNR","MADE","HWAY","PCG","TROW","PTGX","RDW","KALU","AFRU","CRM","MDB","RVMD","PATH","ADSK","BRCC","AFRM","EIX","CACI","SRE","BPOP","BW","IBM","BCDF","XTL","CIEN","ETR","FIVN","FTAG","ATI","HONA","BURL","ICE","ASST","SCTX","PYPL","ANF","ADBE","DLTR","RBRK","ATTO","AIRJ","DE","BILT","TPZ","BRVE","RKLB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663027370","title":"TipRanks Analyst Salveen Richter Reiterates Buy on Braveheart Bio, Sets $48 12-Month Target on Strong HCM Opportunity for Lead Asset BHB-1893","url":"https://stock-news.laohu8.com/highlight/detail?id=2663027370","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663027370?lang=en_us&edition=fundamental","pubTime":"2026-08-31 14:16","pubTimestamp":1788156960,"startTime":"0","endTime":"0","summary":"Braveheart Bio, Inc. (BRVE) has received a new Buy rating, initiated by Goldman Sachs analyst, Salveen Richter. Salveen Richter has given his Buy r...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/tipranks-analyst-salveen-richter-reiterates-buy-on-braveheart-bio-sets-48-12-month-target-on-strong-hcm-opportunity-for-lead-asset-bhb-1893-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/tipranks-analyst-salveen-richter-reiterates-buy-on-braveheart-bio-sets-48-12-month-target-on-strong-hcm-opportunity-for-lead-asset-bhb-1893-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DBB","LU1868837300.USD","LU2471134952.CNY","LU0868494617.USD","LU2896262040.SGD","LU1894683348.USD","BK4504","BK4588","LU0106831901.USD","LU2237443549.SGD","IE0004086264.USD","BK4552","IE0002270589.USD","BK4585","LU1868836914.USD","LU2750360997.AUD","LU0868494708.USD","BK4516","LU0096364046.USD","LU1868837136.USD","LU1791807156.HKD","IE0004091025.USD","LU2471134879.HKD","BK4550","BK4533","BHB","GSX","LU2750360641.GBP","LU2265009873.SGD","LU0061475181.USD","LU1804176565.USD","LU1868836591.USD","BK4127","BRVE","LU2237438978.USD","LU2237443622.USD","LU2237443895.HKD","LU0251142724.SGD","LU1868836757.USD","LU2471134796.USD","LU2237443382.USD","LU1668664300.SGD","IE0034235188.USD","IE00BFXG1179.USD","LU0251131958.USD","LU0942090050.USD","LU0210536198.USD","BK4211","IE00B19Z3B42.SGD","LU0345770308.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659243121","title":"Braveheart Bio Director Vineeta Agarwala Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2659243121","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659243121?lang=en_us&edition=fundamental","pubTime":"2026-08-15 05:05","pubTimestamp":1786741522,"startTime":"0","endTime":"0","summary":"Braveheart Bio director Vineeta Agarwala files initial beneficial ownership statementDirector Vineeta Agarwala filed an initial Form 3 for Braveheart Bio, reporting indirect ownership of 10,232,420 co","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL4ChQML:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BRVE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658947790","title":"Insiders Double Down on Braveheart Bio in Massive Confidence Play","url":"https://stock-news.laohu8.com/highlight/detail?id=2658947790","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658947790?lang=en_us&edition=fundamental","pubTime":"2026-08-12 10:01","pubTimestamp":1786500109,"startTime":"0","endTime":"0","summary":"New insider activity at Braveheart Bio, Inc. ( ($BRVE) ) has taken place on August 11, 2026. Braveheart Bio, Inc. has attracted substantial insider...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/insiders-double-down-on-braveheart-bio-in-massive-confidence-play-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/insiders-double-down-on-braveheart-bio-in-massive-confidence-play-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BRVE"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":35,"code":"91000000","status":"200"}]}}